Endpoints News 生物医药· Kyle LaHucik·· 18 天前AI 评分25
CinRx 与 Sam Waksal 的 Graviton 合作开发 ROCK2 用于肺动脉高压及其他心血管疾病
CinRx teams with Sam Waksal's Graviton on ROCK2 for PAH, other cardio conditions
AI 导读
CinRx 与 Sam Waksal 的 Graviton 公司合作,继续开发 ROCK2 药物,旨在治疗肺动脉高压及其他心血管疾病。
正文
Sam Waksal is doubling down on ROCK2 after his first work on the target led to the chronic graft-versus-host disease medicine Rezurock.
Now, the Graviton …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news